All News

Giredestrant plus Afinitor may help patients with metastatic breast cancer delay chemotherapy and stay on effective treatment longer.

Patients with cancer taking GLP-1 drugs alongside immunotherapy had better long-term survival and fewer immune-related side effects.

Study data shows Ibtrozi provides rapid symptom relief and stable brain health for patients with advanced ROS1-positive lung cancer.

Dr. Emily Podany links food deserts to aggressive breast cancer mutations and shorter survival, stressing the need for social determinant screening.

OPTIMA trial data at ASCO 2026 shows a 50-gene test helps patients with high-risk breast cancer avoid unnecessary and toxic chemotherapy treatments.

Dr. Paolo Tarantino discusses the importance of strategic sequencing and drug-specific prophylaxis to optimize ADC therapy in breast cancer.

KEYNOTE-522 trial data shows adding Keytruda to chemotherapy drastically improves long-term survival for high-risk, early-stage TNBC.

ASCO 2026: MajesTEC-9 trial shows Tecvayli cuts death risk by 40% and improves outcomes in relapsed/refractory multiple myeloma patients.

Mezigdomide, Kyprolis and dexamethasone cut progression risk by 52% in relapsed or refractory multiple myeloma.

Sac-TMT plus Keytruda helped patients with PD-L1–positive advanced NSCLC live longer without their cancer worsening and increased response rates versus Keytruda alone.

Patients with EGFR exon 20-positive NSCLC had longer progression-free survival with Zegfrovy than chemotherapy.

Thriving does not begin when treatment ends. It starts the moment we find our voice in the messy, uncertain middle of the journey

First-in-human pancreatic cancer trial at WVU tests an implant that delivers chemotherapy directly into tumors using low-voltage electric pulses.

A cancer survivor’s wife created a life transition binder during his treatment to organize medical, financial and household information to access details in emergencies.

How a Facebook reunion between two former reporters grew into a vital bond of shared support, hope and courage during their experiences with cancer.

FDA approves Imfinzi plus BCG for adults with high-risk non-muscle invasive bladder cancer based on phase 3 POTOMAC trial results.

Dr. Maurie Markman, joins The Moonlight Shift to discuss precision medicine's real-world limits, oncology's cost crisis, CAR-T in solid tumors, and the decision support gap costing patients.

FDA approves Decnupaz for adults with BPDCN, with 69.7% of treatment-naïve patients achieving remission in the CADENZA trial.

A healthy, active 39-year-old shares how blood in his urine led to a bladder cancer diagnosis and becoming first in Texas to receive Inlexzo.

A cancer survivor shares the raw reality of scanxiety, coping with potential recurrence and finding hope during hard medical journeys.

ASCO 2026 will feature new gynecologic cancer research, including advances in immunotherapy, ADCs, vaccines and targeted therapies.

Dr. Alexis LeVee and a resilient survivor explore the vital role of self-advocacy in breast cancer care across ages and medical guidelines.

Discover how a multiple myeloma survivor manages treatment and daily anxiety through Qigong, rituals and self-care.

After losing his mother to colorectal cancer, Colorectal Cancer Alliance CEO Michael Sapienza turned grief into advocacy to improve screening, treatment and patient care.

Discover five breakthrough breast cancer studies disrupting oncology as global research teams unveil practice-changing data at ASCO 2026 in Chicago.

After Diane Montalto’s stage 4 colon cancer diagnosis, she and daughter Alyssa turned fear, family support and survival into hope for others.

An inspiring BRCA2 survivor shares her mastectomy journey, launching the Dear Body Project to help women find healing, self-love and community.

Discover how mastectomy-induced sensation loss impacts body image and intimacy, and learn how breast cancer survivors can advocate for their recovery.